This is neither an endorsement or advice about the treatment of mental health.
It goes without saying that good mental health is foundational to overall health and well-being.
In underwriting, a report of confirmed or even suspected history of depression or related conditions gets a lot of attention and policy issue can range from standard rates to rated premium to sometimes no offer at all, where the risk is deemed too high to accept.
Treatments for depression, bipolar disorder, schizophrenia or other conditions in the mental health spectrum continue to evolve. The use of psychedelics is a newer facet of treatment. Natural substances that induce a hallucinatory state have been around for millennia. These include everything from cannabis, now legal in Canada, and include opium poppy to ayahuasca, the latter a product of brewing a particular vine or shrub commonly found in South America (1). Continue reading “The Evolving World of Mental Health Treatments”